- Home
- BLCO vs CTRE Comparison
BLCO vs CTRE Comparison
Compare BLCO & CTRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BLCO
- CTRE
- Stock Information
- Founded
- BLCO 1853
- CTRE 2013
- Country
- BLCO Canada
- CTRE United States
- Employees
- BLCO N/A
- CTRE N/A
- Industry
- BLCO Ophthalmic Goods
- CTRE Real Estate Investment Trusts
- Sector
- BLCO Health Care
- CTRE Real Estate
- Exchange
- BLCO Nasdaq
- CTRE Nasdaq
- Market Cap
- BLCO 4.0B
- CTRE 4.1B
- IPO Year
- BLCO 2022
- CTRE N/A
- Fundamental
- Price
- BLCO $11.87
- CTRE $28.76
- Analyst Decision
- BLCO Hold
- CTRE Buy
- Analyst Count
- BLCO 12
- CTRE 7
- Target Price
- BLCO $18.64
- CTRE $30.86
- AVG Volume (30 Days)
- BLCO 906.7K
- CTRE 1.8M
- Earning Date
- BLCO 04-30-2025
- CTRE 05-01-2025
- Dividend Yield
- BLCO N/A
- CTRE 4.68%
- EPS Growth
- BLCO N/A
- CTRE 60.00
- EPS
- BLCO N/A
- CTRE 0.80
- Revenue
- BLCO $4,791,000,000.00
- CTRE $296,286,000.00
- Revenue This Year
- BLCO $6.43
- CTRE $17.20
- Revenue Next Year
- BLCO $5.59
- CTRE $16.94
- P/E Ratio
- BLCO N/A
- CTRE $35.51
- Revenue Growth
- BLCO 15.56
- CTRE 36.05
- 52 Week Low
- BLCO $10.46
- CTRE $23.26
- 52 Week High
- BLCO $21.69
- CTRE $33.15
- Technical
- Relative Strength Index (RSI)
- BLCO 36.46
- CTRE 60.29
- Support Level
- BLCO $10.46
- CTRE $27.02
- Resistance Level
- BLCO $12.38
- CTRE $28.08
- Average True Range (ATR)
- BLCO 0.92
- CTRE 0.92
- MACD
- BLCO -0.09
- CTRE 0.02
- Stochastic Oscillator
- BLCO 33.02
- CTRE 84.06
About BLCO Bausch + Lomb Corporation
Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.
About CTRE CareTrust REIT Inc.
CareTrust REIT Inc is a self-administered, publicly-traded REIT engaged in the ownership, acquisition, financing, development and leasing of skilled nursing, seniors housing and other healthcare-related properties. The Company has one reportable segment consisting of investments in healthcare-related real estate assets. It generates revenues by leasing healthcare-related properties to healthcare operators in triple-net lease arrangements. The Company generate revenues by leasing healthcare-related properties to healthcare operators in triple-net lease arrangements, under which the tenant is solely responsible for the costs related to the property (including property taxes, insurance, maintenance and repair costs and capital expenditures).